[{"Assets_0_Q1_USD":434390000.0,"CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q1_USD":0.04,"EarningsPerShareDiluted_1_Q1_USD":0.04,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":14291000.0,"NetIncomeLossConverted_1_Q1_USD":449000.0,"OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q1_USD":52887000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q1_USD":199712000.0,"Ticker":"ANIP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":11823000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":11747000.0,"filed":"20190509","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2019.0","name":"ANI PHARMACEUTICALS INC","period":"20190331","qtrs":"0","uom":"USD"}]